|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���� |
|
һ������ |
|
ϸ������ |
| ��������������� | |
|
̷ѩ�� |
|
Ϳ��ϼ |
|
����Ȼ |
| PubMed | |
|
Article by ̷ѩ�� |
|
Article by Ϳ��ϼ |
|
Article by ����Ȼ |
������һ�����������������
̷ѩ��1, Ϳ��ϼ2, ����Ȼ1
1. ����ҽ�ƴ�ѧ������һҽԺƤ����, ����116011;
2. ����ҽ�ƴ�ѧ�����ڶ�ҽԺƤ����
һ��������һ��ϸ������ʹ,�������ֱ�������һ��ϸ����ЧӦ����,�ɲ����������߲��ķ���,��ϳɺ�����ѧЧӦ�ܶ���ϸ�����ӵ��ء�������һ�ֻ����ɫ����ʧ��Ƥ����,һ����������ͨ���������ϸ���ƻ��͵������������ڰ��緢���������á�����������һ����������ϸ�������ڰ��緢�������еĿ������á�
1. ����ҽ�ƴ�ѧ������һҽԺƤ����, ����116011;
2. ����ҽ�ƴ�ѧ�����ڶ�ҽԺƤ����
1. ����ҽ�ƴ�ѧ������һҽԺƤ����, ����116011;
2. ����ҽ�ƴ�ѧ�����ڶ�ҽԺƤ����
[2] Jackson M, Frame F, Weller R, et al. Expression of nitric oxide synthase �� (eNOS) mRNA by human skin cells:melanocytes but not keratinocytes express eNOS mRNA. Arch Dermatol Res, 1998, 290(6):350-352.
[3] Singh VK, Mehrotra S, Narayan P, et al. Modulation of autoimmune diseases by nitric oxide. Immunol Res, 2000, 22(1):1-19.
[4] Liaudet L, Soriano FG, Szabo C. Biology of nitric oxide signaling.Crit Care Med, 2000, 28(4 Suppl):N37-52.
[5] Rocha IM, Guillo LA. Lipopolysaccharide and cytokines induce nitric oxide synthase and produce nitric oxide in cultured normal human melanocytes. Arch Dermatol Res, 2001, 293 (5):245-248.
[6] Brune B, Sandau K, von Knethen A. Apoptotic cell death and nitric oxide:activating and antagonistic transducing pathways. Biochemistry (Mosc), 1998, 63 (7):817-825.
[7] Kroncke KD, Brenner HH, Rodriguez ML,et al. Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitric oxide. Biochim Biophys Acta, 1993, 1182(2):221-229.
[8] Ivanova K, Le Poole IC, Gerzer R, et al. Effect of nitric oxide on the adhesion of human melanocytes to extracellular matrix components. J Pathol, 1997, 183(4):469-476.
[9] Kolb H, Kolb-Bachofen V. Nitric oxide:a pathogenetic factor in autoimmunity. Immunol Today, 1992, 13(5):157-160.
[10] Kroncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide:cytotoxicity versus cytoprotection-how, why, when, and where? Nitric Oxide,1997, 1(2):107-120.
[11] Chang RH, Feng MH, Liu WH, et al. Nitric oxide increased intedeukin-4 expression in T lymphocytes. Immunology, 1997, 90 (3):364-369.
[12] Niedbala W, Wei XQ, Piedrafita D,et al. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol, 1999, 29(8):2498-2505.
[13] Huang FP, Niedbala W, Wei XQ,et al. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Ear J Immunol, 1998, 28(12):4062-4070.
[14] Mulligan MS, Hevel JM, Marietta MA, et al. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci U S A, 1991, 88(14):6338-6342.
[15] Kroemer G, Martinez C. Cytokines and autoimmune disease. Clin Immunol Immunopathol, 1991,61 (3):275-295.
[16] Liew FY. Regulation of nitric oxide synthesis in infectious and autoimmune diseases. Immunol Lett, 1994, 43 (1-2):95-98.
[17] Morelli JG, Norris DA. Influence of inflammatory mediators and cytokines on human melanocyte function. J Invest Dermatol, 1993, 100(2Suppl):S191-S195.
[18] Das L, Datta N, Bandyopadhyay S, et al. Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol, 2001, 166(6):4020-4028.
[19] Tarrant TK, Silver PB, Wahlsten JL, et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma,nitric oxide, and apoptosis. J Exp Med, 1999, 189(2):219-230.
[20] Zidek Z, Lotzova E, Frankova D, et al. Indirect stimulatory effects of murine interleukin-12 on in vitro production of nitric oxide by mouse peritoneal cells. J Interferon Cytokine Res, 1996, 16(5):389-393.
[21] Lasarte JJ, Corrales FJ, Casares N, et al. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen:the role of nitric oxide. J Immunol, 1999,162(9):5270-5277.
[22] Goff WL, Johnson WC, Cluff CW. Babesia bovis immunity. In vitro and in vivo evidence for IL-10 regulation of IFN-gamma and iNOS.Ann N Y Acad Sci, 1998, 849:161-180.
[23] Becherel PA, Le Goff L, Ktorza S, et al. Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes. Eur J Immunol, 1995, 25(10):2992-2995.
[24] Mallat Z, Heymes C, Ohan J, et al. Expressior of interleukin-10 in advanced human atherosclerotic plaques:relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol, 1999, 19(3):611-616.
[25] Relic B, Guicheux J, Mezin F,et al. ��-4 and IL-13, but not IL 10, protect human synoviocytes from apoptosis. J Immunol, 2001,166(4):2775-2782.
[26] Molina-Holgado E, Vela JM, Arevalo-Martin A, et al. LPS/IFN-gamma cytotoxicity in oligodendroglial cells:role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci. 2001,13(3):493-502.
[27] Patton EA, La Flamme AC, Pedras-Vasoncelos JA, et al. Central role for interleukin-4 in regulating nitric oxide-mediated inhibition of Tcell proliferation and gamma interferon production in schistosomiasis.Infect Immun, 2002, 70(1):177-184.